276 related articles for article (PubMed ID: 33024108)
21. Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation.
Peterse EFP; Niessen B; Addie RD; de Jong Y; Cleven AHG; Kruisselbrink AB; van den Akker BEWM; Molenaar RJ; Cleton-Jansen AM; Bovée JVMG
Br J Cancer; 2018 Apr; 118(8):1074-1083. PubMed ID: 29576625
[TBL] [Abstract][Full Text] [Related]
22. The biology and management of cartilaginous tumors: a role for targeting isocitrate dehydrogenase.
Tinoco G; Wilky BA; Paz-Mejia A; Rosenberg A; Trent JC
Am Soc Clin Oncol Educ Book; 2015; ():e648-55. PubMed ID: 25993236
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-100 resensitizes resistant chondrosarcoma cells to cisplatin through direct targeting of mTOR.
Zhu Z; Wang CP; Zhang YF; Nie L
Asian Pac J Cancer Prev; 2014; 15(2):917-23. PubMed ID: 24568519
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA regulates vascular endothelial growth factor expression in chondrosarcoma cells.
Sun X; Wei L; Chen Q; Terek RM
Clin Orthop Relat Res; 2015 Mar; 473(3):907-13. PubMed ID: 25106798
[TBL] [Abstract][Full Text] [Related]
25. Anti-miRNA Oligonucleotide Therapy for Chondrosarcoma.
Sun X; Chen Y; Yu H; Machan JT; Alladin A; Ramirez J; Taliano R; Hart J; Chen Q; Terek RM
Mol Cancer Ther; 2019 Nov; 18(11):2021-2029. PubMed ID: 31341031
[TBL] [Abstract][Full Text] [Related]
26. A MALAT1/HIF-2α feedback loop contributes to arsenite carcinogenesis.
Luo F; Sun B; Li H; Xu Y; Liu Y; Liu X; Lu L; Li J; Wang Q; Wei S; Shi L; Lu X; Liu Q; Zhang A
Oncotarget; 2016 Feb; 7(5):5769-87. PubMed ID: 26735578
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.
Zhao D; Zhai B; He C; Tan G; Jiang X; Pan S; Dong X; Wei Z; Ma L; Qiao H; Jiang H; Sun X
Cell Signal; 2014 May; 26(5):1030-9. PubMed ID: 24486412
[TBL] [Abstract][Full Text] [Related]
28. HIF-2α regulates non-canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma.
Li W; Chen C; Zhao X; Ye H; Zhao Y; Fu Z; Pan W; Zheng S; Wei L; Nong T; Li Z; Chen R
J Cell Mol Med; 2017 Nov; 21(11):2896-2908. PubMed ID: 28544376
[TBL] [Abstract][Full Text] [Related]
29. Novel strategies for the treatment of chondrosarcomas: targeting integrins.
Chen JC; Fong YC; Tang CH
Biomed Res Int; 2013; 2013():396839. PubMed ID: 24490159
[TBL] [Abstract][Full Text] [Related]
30. HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer.
Jarman EJ; Ward C; Turnbull AK; Martinez-Perez C; Meehan J; Xintaropoulou C; Sims AH; Langdon SP
Breast Cancer Res; 2019 Jan; 21(1):10. PubMed ID: 30670058
[TBL] [Abstract][Full Text] [Related]
31. Estrogen signaling is active in cartilaginous tumors: implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma.
Cleton-Jansen AM; van Beerendonk HM; Baelde HJ; Bovée JV; Karperien M; Hogendoorn PC
Clin Cancer Res; 2005 Nov; 11(22):8028-35. PubMed ID: 16299232
[TBL] [Abstract][Full Text] [Related]
32. [Inflammation as molecular target in chondrosarcoma].
Kalinski T
Pathologe; 2014 Nov; 35 Suppl 2():249-53. PubMed ID: 25394974
[TBL] [Abstract][Full Text] [Related]
33. Downregulating hypoxia-inducible factor-2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma.
He C; Sun XP; Qiao H; Jiang X; Wang D; Jin X; Dong X; Wang J; Jiang H; Sun X
Cancer Sci; 2012 Mar; 103(3):528-34. PubMed ID: 22145922
[TBL] [Abstract][Full Text] [Related]
34. LncRNA HIF2PUT inhibited osteosarcoma stem cells proliferation, migration and invasion by regulating HIF2 expression.
Zhao D; Wang S; Chu X; Han D
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1342-1348. PubMed ID: 30966832
[TBL] [Abstract][Full Text] [Related]
35. Amphiregulin enhances alpha6beta1 integrin expression and cell motility in human chondrosarcoma cells through Ras/Raf/MEK/ERK/AP-1 pathway.
Chen JC; Chen YJ; Lin CY; Fong YC; Hsu CJ; Tsai CH; Su JL; Tang CH
Oncotarget; 2015 May; 6(13):11434-46. PubMed ID: 25825984
[TBL] [Abstract][Full Text] [Related]
36. The hypoxia-associated factor switches cells from HIF-1α- to HIF-2α-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion.
Koh MY; Lemos R; Liu X; Powis G
Cancer Res; 2011 Jun; 71(11):4015-27. PubMed ID: 21512133
[TBL] [Abstract][Full Text] [Related]
37. HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression.
Harashima N; Takenaga K; Akimoto M; Harada M
Oncotarget; 2017 Jun; 8(26):42887-42900. PubMed ID: 28476028
[TBL] [Abstract][Full Text] [Related]
38. Estrogen-dependent downregulation of hypoxia-inducible factor (HIF)-2α in invasive breast cancer cells.
Fuady JH; Gutsche K; Santambrogio S; Varga Z; Hoogewijs D; Wenger RH
Oncotarget; 2016 May; 7(21):31153-65. PubMed ID: 27105516
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone.
Chen S; Fritchie K; Wei S; Ali N; Curless K; Shen T; Brini AT; Latif F; Sumathi V; Siegal GP; Cheng L
Hum Pathol; 2017 Jul; 65():239-246. PubMed ID: 28552826
[TBL] [Abstract][Full Text] [Related]
40. microRNA-558 facilitates the expression of hypoxia-inducible factor 2 alpha through binding to 5'-untranslated region in neuroblastoma.
Qu H; Zheng L; Song H; Jiao W; Li D; Fang E; Wang X; Mei H; Pu J; Huang K; Tong Q
Oncotarget; 2016 Jun; 7(26):40657-40673. PubMed ID: 27276678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]